ZJYL
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
NASDAQ: ZJYL · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$2.17
-1.81% today
Updated 2026-04-30
Market cap
$18.00M
P/E ratio
11.50
P/S ratio
0.87x
EPS (TTM)
$0.20
Dividend yield
—
52W range
$2 – $18
Volume
0.1M
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.91M | $20.37M | $16.19M | $20.76M | $19.19M | $19.82M | $23.50M | $20.69M |
| Revenue growth (YoY) | — | -2.6% | -20.5% | +28.2% | -7.6% | +3.3% | +18.6% | -12.0% |
| Cost of revenue | $13.25M | $12.86M | $10.70M | $14.40M | $12.99M | $13.04M | $14.00M | $14.64M |
| Gross profit | $7.66M | $7.51M | $5.50M | $6.36M | $6.20M | $6.78M | $9.50M | $6.04M |
| Gross margin | 36.6% | 36.9% | 34.0% | 30.6% | 32.3% | 34.2% | 40.4% | 29.2% |
| R&D | $1.20M | $1.13M | $1.26M | $1.57M | $1.89M | $1.54M | $1.50M | $1.56M |
| SG&A | $1.72M | $1.60M | $1.50M | $1.67M | $1.77M | $2.37M | $3.26M | $2.53M |
| Operating income | $4.23M | $4.40M | $2.35M | $2.63M | $2.13M | $2.87M | $3.64M | $608182.00 |
| Operating margin | 20.2% | 21.6% | 14.5% | 12.7% | 11.1% | 14.5% | 15.5% | 2.9% |
| EBITDA | $4.60M | $4.75M | $2.79M | $3.23M | $3.10M | — | $3.98M | $932865.00 |
| EBITDA margin | 22.0% | 23.3% | 17.2% | 15.6% | 16.2% | 0.0% | 17.0% | 4.5% |
| EBIT | $4.23M | $4.40M | $2.47M | $2.89M | $2.74M | — | $3.64M | $608182.00 |
| Interest expense | — | $22846.00 | $112404.00 | $9492.00 | — | — | — | — |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $3.68M | $3.65M | $2.21M | $2.63M | $2.71M | $2.88M | $3.68M | $1.19M |
| Net income growth (YoY) | — | -0.9% | -39.5% | +19.3% | +2.8% | +6.3% | +27.7% | -67.6% |
| Profit margin | 17.6% | 17.9% | 13.6% | 12.7% | 14.1% | 14.5% | 15.6% | 5.8% |